These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39141)

  • 1. The stability of betamethasone-17-valerate in semi-solid bases.
    Yip YW; Po LW
    J Pharm Pharmacol; 1979 Jun; 31(6):400-2. PubMed ID: 39141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-performance liquid chromatographic assay of betamethasone 17-valerate and its degradation products.
    Li Wan Po A; Irwin WJ; Yip YW
    J Chromatogr; 1979 Sep; 176(3):399-405. PubMed ID: 546923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The stability and blanching efficacy of betamethasone-17-valerate in emulsifying ointment.
    Ryatt KS; Feather JW; Mehta A; Dawson JB; Cotterill JA; Swallow R
    Br J Dermatol; 1982 Jul; 107(1):71-6. PubMed ID: 7104209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The stability and blanching efficiency of some Betnelan-V cream dilutions.
    Boonsaner P; Remon JP; De Rudder D
    J Clin Hosp Pharm; 1986 Apr; 11(2):101-6. PubMed ID: 3711358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of serial dilution of betamethasone-17-valerate on blanching potential and chemical stability.
    Ryatt KS; Cotterill JA; Mehta A
    J Clin Hosp Pharm; 1983 Jun; 8(2):143-5. PubMed ID: 6875011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of betamethasone 17-valerate from extemporaneous dilutions of a proprietary topical cream.
    Magnus AD; Haigh JM; Kanfer I
    Dermatologica; 1981; 163(4):331-7. PubMed ID: 7308554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro diffusion cell design and validation. I. A stability-indicating high-performance liquid chromatographic assay for betamethasone 17-valerate in purified isopropyl myristate receptor phase.
    Smith EW; Haigh JM
    Pharm Res; 1989 May; 6(5):431-5. PubMed ID: 2748536
    [No Abstract]   [Full Text] [Related]  

  • 8. Formulation factors affecting the isomerization rate of betamethasone-17-valerate in a developmental hydrophilic cream - a HPLC and microscopy based stability study.
    Byrne J; Wyraz A; Velasco-Torrijos T; Reinhardt R
    Pharm Dev Technol; 2017 Jun; 22(4):537-544. PubMed ID: 26895450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous Determination of Cinchocaine Hydrochloride and Betamethasone Valerate in Presence of Their Degradation Products.
    Fayed AS; Rezk MR; Marzouk HM; Abbas SS
    J Chromatogr Sci; 2017 May; 55(5):518-527. PubMed ID: 28168304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stability and blanching efficiency of betamethasone-17-valerate in emulsifying ointment.
    Kirsch JM; Gibson JR; Darley CR
    Br J Dermatol; 1983 Feb; 108(2):250-1. PubMed ID: 6824582
    [No Abstract]   [Full Text] [Related]  

  • 11. [Betamethasone valerate reference standard (Control 941) of the National Institute of Health Sciences].
    Kitajima A; Tanimoto T; Okada S
    Eisei Shikenjo Hokoku; 1995; (113):111-3. PubMed ID: 8717241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dilution of betamethasone ointment.
    Smith JF; Beveridge EG; Orr NA
    Br J Dermatol; 1983 Feb; 108(2):248-50. PubMed ID: 6824581
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability indicating liquid chromatographic method for simultaneous quantification of betamethasone valerate and tazarotene in in vitro and ex vivo studies of complex nanoformulation.
    Rapalli VK; Singhvi G; Gorantla S; Waghule T; Dubey SK; Saha RN; Hasnain MS; Nayak AK
    J Sep Sci; 2019 Nov; 42(22):3413-3420. PubMed ID: 31529758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and degradation of betamethasone 17-valerate in homogenized living skin equivalent.
    Kubota K; Ademola J; Maibach HI
    Dermatology; 1994; 188(1):13-7. PubMed ID: 8305748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An RP-HPLC Method for the Stability-Indicating Analysis of Impurities of Both Fusidic Acid and Betamethasone-17-Valerate in a Semi-Solid Pharmaceutical Dosage Form.
    Byrne J; Velasco-Torrijos T; Reinhardt R
    J Chromatogr Sci; 2015 Oct; 53(9):1498-503. PubMed ID: 25896658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind trial of budesonide ointment and betamethasone-17-valerate ointment in psoriasis.
    Schmidt H; Hjorth N; Salde L
    J Int Med Res; 1981; 9(3):236-8. PubMed ID: 7016629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous diffusion and metabolism of betamethasone 17-valerate in the living skin equivalent.
    Kubota K; Ademola J; Maibach HI
    J Pharm Sci; 1995 Dec; 84(12):1478-81. PubMed ID: 8748331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of a novel corticosteroid nasal irrigation solution: betamethasone 17-valerate added to extemporaneously prepared nasal irrigation solutions.
    Ong KY; Lim WC; Ooi SM; Loh ZH; Kong MC; Chan LW; Heng PWS
    Int Forum Allergy Rhinol; 2017 May; 7(5):494-501. PubMed ID: 28092126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous HPLC Determination of Betamethasone Esters-Containing Mixtures: Analysis of Their Topical Preparations.
    Hassib ST; Mahrouse MA; Elkady EF; Sayed RM
    J Chromatogr Sci; 2018 Sep; 56(8):716-723. PubMed ID: 29800112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The response of psoriasis to betamethasone valerate and clobetasol propionate. A 6-month controlled study.
    Corbett MF
    Br J Dermatol; 1976 Mar; 94 suppl 12():89-93. PubMed ID: 773414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.